New TB drug too costly for many in SA
29 February 2016 - 02:32
A new TB drug that can treat multidrug-resistant strains of the disease and will not cause the severe side effects of older treatments is soon to be available in South Africa. The drug, Delamanid, developed by the Japanese Otsuka drug company, was approved by the European Medicines Agency in 2014.Otsuka and the UN body Stop TB launched the drug last week.
This article is reserved for Sunday Times subscribers.
A subscription gives you full digital access to all Sunday Times content.
Please visit SundayTimes.co.za in your desktop to view our latest subscription options.
Already subscribed? Simply sign in below.
Sign InQuestions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.